Mollard Rebecca, Cachero Katrina, Luhovyy Bohdan, Martin Heather, Moisiuk Sharon, Mahboobi Sepideh, Balshaw Robert, Collister David, Cahill Leah, Tennankore Karthik K, Tangri Navdeep, MacKay Dylan
Department of Food and Human Nutritional Sciences, Faculty of Agriculture and Food Science, University of Manitoba, Winnipeg, Canada.
Chronic Disease Innovation Centre, Seven Oaks General Hospital, University of Manitoba, Winnipeg, Canada.
Can J Kidney Health Dis. 2023 Aug 7;10:20543581231190180. doi: 10.1177/20543581231190180. eCollection 2023.
Individuals with chronic kidney disease (CKD) can develop metabolic acidosis which, in turn, is associated with faster progression of CKD and an increased need for dialysis. Oral sodium bicarbonate (the current standard of care therapy for metabolic acidosis) is poorly tolerated leading to low adherence. Base-producing or alkalizing Fruit and vegetables have potential as an alternative treatment for metabolic acidosis as they have been shown to reduce acid load arising from the diet.
This trial will evaluate the feasibility of providing base-producing fruit and vegetables as a dietary treatment for metabolic acidosis, compared with oral sodium bicarbonate.
A 2-arm, open-label, dual-center, randomized controlled feasibility trial.
Two Canadian sites: a nephrology clinic in Winnipeg, Manitoba, and a nephrology clinic in Halifax, Nova Scotia.
Adult participants with G3-G5 CKD and metabolic acidosis.
Participants will undergo baseline measurements and attend 5 study visits over 12 months at which they will have a measurement of feasibility criteria as well as blood pressure, blood and urine biochemistry, 5-repetition chair stand test (STS5), and questionnaires to assess quality of life and symptoms. Furthermore, participants fill out Automated Self-Administered 24-hour recalls (ASA-24) in the beginning, middle, and end of trial.
A total of 40 eligible participants will be randomized 1:1 to either base-producing fruit and vegetables (experimental) group or sodium bicarbonate (control) group, beginning from a daily dose of 1500 mg.
Using self-administered dietary assessments, lack of supervision over the consumption of study treatments and the possible disappointment of the control group for not receiving fruit and vegetables would be considered as limitations for this study. However, we are planning to undertake proper practices to overcome the possible limitations. These practices are discussed throughout the article in detail.
This study will generate data on base-producing fruit and vegetables consumption as a dietary treatment for metabolic acidosis in CKD. The data will be used to design a future multi-center trial looking at slowing CKD progression in people with metabolic acidosis.
This study is registered on clinicaltrials.gov with the identifier NCT05113641.
慢性肾脏病(CKD)患者可发生代谢性酸中毒,而代谢性酸中毒又与CKD进展加快及透析需求增加有关。口服碳酸氢钠(目前治疗代谢性酸中毒的标准护理疗法)耐受性差,导致依从性低。产碱或碱化的水果和蔬菜有可能作为代谢性酸中毒的替代治疗方法,因为它们已被证明可减少饮食产生的酸负荷。
本试验将评估提供产碱水果和蔬菜作为代谢性酸中毒饮食治疗方法的可行性,并与口服碳酸氢钠进行比较。
一项双臂、开放标签、双中心随机对照可行性试验。
加拿大的两个地点:马尼托巴省温尼伯的一家肾脏病诊所和新斯科舍省哈利法克斯的一家肾脏病诊所。
患有G3 - G5期CKD和代谢性酸中毒的成年参与者。
参与者将接受基线测量,并在12个月内参加5次研究访视,期间将测量可行性标准以及血压、血液和尿液生化指标、5次重复坐立试验(STS5),并通过问卷评估生活质量和症状。此外,参与者在试验开始、中期和结束时填写自动自我管理的24小时饮食回顾(ASA - 24)。
从每日剂量1500毫克开始,总共40名符合条件的参与者将按1:1随机分为产碱水果和蔬菜(试验)组或碳酸氢钠(对照)组。
使用自我管理的饮食评估、对研究治疗的消费缺乏监督以及对照组可能因未接受水果和蔬菜而感到失望,将被视为本研究的局限性。然而,我们正计划采取适当措施来克服可能的局限性。本文将详细讨论这些措施。
本研究将生成关于食用产碱水果和蔬菜作为CKD患者代谢性酸中毒饮食治疗的数据。这些数据将用于设计未来的多中心试验,研究减缓代谢性酸中毒患者的CKD进展情况。
本研究已在clinicaltrials.gov上注册,标识符为NCT05113641。